LCM
EIGR
Laurion Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-72,925
| Closed | -$621K | – | 644 |
|
|
2021
Q2 | $621K | Sell |
72,925
-109,707
| -60% | -$934K | ﹤0.01% | 281 |
|
|
2021
Q1 | $1.62M | Sell |
182,632
-69,329
| -28% | -$613K | 0.01% | 251 |
|
|
2020
Q4 | $3.1M | Buy |
+251,961
| New | +$3.1M | 0.02% | 119 |
|
|
2019
Q2 | – | Sell |
-114,038
| Closed | -$1.59M | – | 889 |
|
|
2019
Q1 | $1.59M | Buy |
114,038
+63,696
| +127% | +$890K | 0.02% | 219 |
|
|
2018
Q4 | $511K | Buy |
+50,342
| New | +$511K | 0.01% | 336 |
|